Home Contact Sitemap

eRAM

encyclopedia of Rare Disease Annotation for Precision Medicine




Disease intestinal disease
Comorbidity C0008313|sclerosing cholangitis
Sentences 20
PubMedID- 25144777 Hepatobiliary manifestations of primary gi diseases in childhood and adolescence are not uncommon and include several well-described associations, such as sclerosing cholangitis with inflammatory bowel disease.
PubMedID- 22722442 On the other hand, igg4-related sclerosing cholangitis is not associated with inflammatory bowel diseases.
PubMedID- 23126164 [clinical characteristics of cases of primary sclerosing cholangitis associated with inflammatory bowel disease].
PubMedID- 24799986 Patients with primary sclerosing cholangitis (psc) complicated by inflammatory bowel disease (ibd) represent a distinct subset of patients with unique characteristics, which have serious clinical implications.
PubMedID- 20740366 Clinical characteristics of inflammatory bowel disease associated with primary sclerosing cholangitis.
PubMedID- 23670229 Background: inflammatory bowel disease (ibd) associated with primary sclerosing cholangitis (psc) is reported to be mild and prone to right-side predominance with rectal sparing.
PubMedID- 25684965 Aim: to review the current literature for the specific clinical characteristics of inflammatory bowel disease (ibd) associated with primary sclerosing cholangitis (psc).
PubMedID- 22156871 Inflammatory bowel disease complicated by primary sclerosing cholangitis and cirrhosis: is restorative proctocolectomy safe.
PubMedID- 23329527 Background and objectives: in up to 80% of cases primary sclerosing cholangitis (psc) is associated with inflammatory bowel diseases (ibd).
PubMedID- 24696608 This is a review of the characteristic findings of inflammatory bowel disease (ibd) associated with primary sclerosing cholangitis (psc) and their usefulness in the diagnosis of sclerosing cholangitis.
PubMedID- 25636976 Objective: inflammatory bowel disease (ibd) patients with concomitant primary sclerosing cholangitis (psc) carry an increased risk of colorectal cancer (crc) and cholangiocarcinoma (cca).
PubMedID- 23485910 Pediatric ulcerative colitis associated with primary sclerosing cholangitis: a distinct form of inflammatory bowel disease.
PubMedID- 23333218 Immunosuppression after liver transplantation for primary sclerosing cholangitis influences activity of inflammatory bowel disease.
PubMedID- 24257037 Inflammatory bowel disease with concurrent sclerosing cholangitis pre and post-fmt.
PubMedID- 23376317 Effects of immunosuppression and liver transplantation on inflammatory bowel disease in patients with primary sclerosing cholangitis.
PubMedID- 26328042 Frequency and risk factors of primary sclerosing cholangitis among patients with inflammatory bowel disease in north-east of iran.
PubMedID- 21456044 Inflammatory bowel disease in patients with primary sclerosing cholangitis: clinical characterization in liver transplanted and nontransplanted patients.
PubMedID- 22339717 Primary sclerosing cholangitis), family history of inflammatory bowel disease, indication for surgery, medical treatment, age at operation, staged procedure, diverting ileostomy and length of follow-up.
PubMedID- 22835578 Primary sclerosing cholangitis and distribution of inflammatory bowel disease.
PubMedID- 22942741 In primary sclerosing cholangitis with inflammatory bowel disease treated with udca, most colonic carcinomas develop in the first years after the start of treatment [15].

Page: 1